Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analogue vs Human Insulin in Type 2 Diabetes
NCT00747409Phase 4Unknown
- Sponsor
- München Klinik
- Start
- Jul 2004
- Primary completion
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin aspart and insulin detemir in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by München Klinik. Primary endpoint: Postprandial blood glucose. Status: unknown.
02
Drugs
insulin aspartinsulin detemir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00747409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00747409.